Eicosanoids and Diabetic Hypertension

作者: K. Schrör

DOI: 10.1007/978-3-642-73232-4_10

关键词: Eicosanoid ProductionMicroangiopathyRisk factorDiabetes mellitusDiseaseThrombotic complicationInternal medicineDiabetic ketoacidosisJuvenile-Onset DiabetesMedicine

摘要: Hypertension is more common in juvenile onset diabetes than the normal population and considered to be a major risk factor this group of patients (Christlieb et al. 1981). More 2.5 million Americans suffer from associated with hypertension (Working Group on Diabetes 1987). The development vascular complications diabetes, namely diabetic macro- microangiopathy prothrombotic stage, eventually combined hypertension, might facilitated by general disturbance defence mechanisms body, being related insulin deficiency. This involves alterations eicosanoid production that are not only important for control secretion (Rosen Hohlfeld 1985; Robertson 1986) but also thrombotic disease. paper reviews present evidence contribution disturbed mellitus particular emphasis hypertension.

参考文章(50)
K. Schror, H. Sinzinger, Prostaglandins in clinical research Alan R. Liss Inc.,New York, NY. ,(1987)
R C Rogers, J A Colwell, C B Loadholt, P V Halushka, Increased platelet thromboxane synthesis in diabetes mellitus. Journal of Laboratory and Clinical Medicine. ,vol. 97, pp. 87- 96 ,(1981)
R. Paul Robertson, Arachidonic acid metabolite regulation of insulin secretion Diabetes \/ Metabolism Reviews. ,vol. 2, pp. 261- 296 ,(1986) , 10.1002/DMR.5610020304
A. Collier, P. Tymkewycz, R. Armstrong, R. J. Young, R. L. Jones, B. F. Clarke, Increased platelet thromboxane receptor sensitivity in diabetic patients with proliferative retinopathy. Diabetologia. ,vol. 29, pp. 471- 474 ,(1986) , 10.1007/BF00453495
H. E. Harrison, A. H. Reece, M. Johnson, Effect of insulin treatment on prostacyclin in experimental diabetes. Diabetologia. ,vol. 18, pp. 65- 68 ,(1980) , 10.1007/BF01228305
Raveendran Pottathil, Shi-Wen Huang, Kuttikatt A. Chandrabose, Essential fatty acids in diabetes and systemic lupus erythematosus (SLE) patients Biochemical and Biophysical Research Communications. ,vol. 128, pp. 803- 808 ,(1985) , 10.1016/0006-291X(85)90118-4
I. Wakabayashi, K. Hatake, N. Kimura, E. Kakishita, K. Nagai, Modulation of vascular tonus by the endothelium in experimental diabetes Life Sciences. ,vol. 40, pp. 643- 648 ,(1987) , 10.1016/0024-3205(87)90265-7
Heather E. Harrison, Ann H. Reece, Malcolm Johnson, Decreased vascular prostacyclin in experimental diabetes. Life Sciences. ,vol. 23, pp. 351- 355 ,(1978) , 10.1016/0024-3205(78)90020-6
M. Arisaka, O. Arisaka, Y. Fukuda, Y. Yamashiro, Prostaglandin Metabolism in Children With Diabetes Mellitus. I. Plasma Prostaglandin E2, F2α, TXB2, and Serum Fatty Acid Levels Journal of Pediatric Gastroenterology and Nutrition. ,vol. 5, pp. 878- 882 ,(1986) , 10.1097/00005176-198611000-00009
P. Wiles, M. Johnson, Plasma prostacyclin-stimulating activity in diabetes mellitus. Hormone and Metabolic Research. ,vol. 17, pp. 610- 611 ,(1985) , 10.1055/S-2007-1013619